A Boston VC firm is launching a new neuroscience company with a $93M investment that aims to treat disorders including ...

MaxCyte's technology will support TG Therapeutics' efforts to develop a CD19 CAR T cell therapy program for autoimmune diseases.

BharatPe has introduced the 'Maha Kumbh Shield' to secure UPI transactions during Mahakumbh 2025 in Prayagraj. This shield protects against cyber thre ...

Inc., a pharmaceutical company currently trading at $0.60 with a market capitalization of $71 million, has been notified by the Nasdaq Stock Market of non-compliance with the minimum bid price ...

Based on insights from Qatar’s top executives, the report explores how CEOs are navigating economic shifts, embracing digital ...

Constantine Chinoporos, the Chief Operating Officer and Chief Business Officer of Applied Therapeutics, Inc. (NASDAQ:APLT), a clinical-stage biopharmaceutical company with a market capitalization of ...

This approach aims to improve treatment for patients with this highly aggressive and treatment-resistant type of breast ...

Experts discuss the current research on the use of digital therapeutics for managing chronic pain in rheumatic disease.

Despite increasing awareness, identifying and mitigating the effects of ACEs remains a significant challenge, particularly ...

CRISPR Therapeutics AG (NASDAQ:CRSP) is a pioneer in gene-editing technology, using its patented gene sequencing platform to ...